Search - tctmd.com

Displaying 201 - 220 of 260

Sort: Relevancy | Date

News Daily News

VA Efforts to Cut HF Readmissions are Working, With No Uptick in Deaths

L.A. McKeown

June 18, 2020

News Daily News

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

L.A. McKeown

June 04, 2020

News Daily News

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Shelley Wood

May 14, 2020

News Daily News

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

Shelley Wood

May 06, 2020

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Shelley Wood

March 30, 2020

News Daily News

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Caitlin E. Cox

March 26, 2020

News Daily News

Missed Opportunities: Many HF Patients Not Tested for CAD

L.A. McKeown

March 20, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Features

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Caitlin E. Cox

December 17, 2019

News Daily News

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

Todd Neale

November 20, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Daily News

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

Caitlin E. Cox

November 04, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

L.A. McKeown

October 21, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Conference News HFSA 2019

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

L.A. McKeown

September 23, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

Advertisement

VA Efforts to Cut HF Readmissions are Working, With No Uptick in Deaths

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Missed Opportunities: Many HF Patients Not Tested for CAD

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

Repeat Target-Lesion PCI: An Option for Public Reporting?

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content